logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
T

Therapeutic Advances in Gastroenterology

IF3.4
论文数1550
被引数3915
期刊论文 1550
发表时间
delete
Renin–angiotensin system inhibitor exposure and survival outcomes in gastroesophageal cancers: A meta-analysis of observational studies肾素-血管紧张素系统抑制剂暴露与胃食管癌患者生存结局：一项观察性研究的Meta分析
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-21
delete0
PREAI
deleteDong Pu; Bo Luo; Jinhai Shen; Weidong Shen
delete分享
delete收藏
Safety outcomes associated with advanced therapy in patients with inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation: A real-world propensity score–matched cohort study在炎症性肠病和原发性硬化性胆管炎患者肝移植后，与先进疗法相关的安全性结局：一项真实世界倾向性评分匹配队列研究
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-15
delete0
PREAI
deleteAvleen Kaur; Shefali Mody; Rachel Chernet; Abdelkader Chaar; Ahmad Nawaz; Ayushi Shah; Abinash Subedi; Savio John; Idan Goren
delete分享
delete收藏
Prevalence and predictors of excessive weight gain after liver transplantation肝移植后超重发生的流行率及其预测因素
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-15
delete0
PREAI
deleteKatrina Tan; Nicola Tomkins; Jack Whitelaw; Darren Wong; Penny Hey; Karl Vaz; Alex Craven; Marie Sinclair
delete分享
delete收藏
Comment on: Pregnancy safety of biologics in inflammatory bowel disease: A systematic review and network meta-analysis评论：炎症性肠病中生物制剂的妊娠安全性：一项系统评价和网络Meta分析
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-14
delete0
PREAI
deleteLiverinto-Panagiotis Mela
delete分享
delete收藏
Prognostic impact of MASLD versus simple hepatic steatosis in HCC patients undergoing hepatectomy: A stratified analysis based on metabolic factors代谢相关脂肪性肝病与单纯性肝脂肪变性对接受肝切除术肝癌患者预后的影响：基于代谢因素的分层分析
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-13
delete0
PREAI
deleteQingyan Kong; Haojia Wang; Jiahui Yang; Zheyu Chen
delete分享
delete收藏
Doxycycline plus vonoprazan for Helicobacter pylori eradication: A multicenter randomized noninferiority trial多西环素联合Vonoprazan根除幽门螺杆菌：一项多中心随机非劣效性试验
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-12
delete0
PREAI
deleteTong Zhang; Tingxu Yang; Zhuoma Cailang; Zhihai He; Lili Ma; Yanhe Zheng; Xiaojuan Kang; Tingting Chen; Shufang Zhang; Sangmao Deji; Songyang Yao; Yongnai Zhuang; Dekui Zhang
delete分享
delete收藏
Vonoprazan in school-aged children and adolescents: A narrative review of emerging evidence for gastroesophageal reflux disease and Helicobacter pylori infection沃诺拉赞在学龄儿童和青少年中的应用：关于胃食管反流病和幽门螺杆菌感染的新兴证据的叙述性综述
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-11
delete0
PREAI
deleteYang Jing; Yang Yu
delete分享
delete收藏
Impact of fecal microbiota transplantation on secretory IgA in chronic pouchitis: A secondary immunological analysis of the MicroPouch study粪菌移植对慢性储袋炎分泌型IgA的影响：MicroPouch研究的一项次要免疫学分析
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-10
delete0
PREAI
deleteSarah Søgaard Jakobsen; Hans Linde Nielsen; Frederik Cold; Sofie Ingdam Halkjær; Andreas Munk Petersen; Jens Kjeldsen; Ole Thorlacius-Ussing; Sabrina Just Kousgaard
delete分享
delete收藏
Combining immunomodulators with biologic therapies vs. biologic monotherapy in patients with inflammatory bowel diseases: Target trial emulations将免疫调节剂与生物制剂联合治疗与生物制剂单药治疗在炎症性肠病患者中的比较：目标试验模拟
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-10
delete0
PREAI
deleteAnna L. Silverman; Dhruv Ahuja; Kuan-Hung Yeh; Ronghui Xu; Shane W. Goodwin; Vipul Jairath; Siddharth Singh
delete分享
delete收藏
CASH-GP score predicts colon adenoma in metabolic dysfunction-associated steatotic liver disease patientsCASH-GP评分预测代谢功能障碍相关脂肪性肝病患者结肠腺瘤
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-10
delete0
PREAI
deleteJen Yu; Chieh Lee; Chia-Yu Lai; Guan-Yu Wang; Shania Andea Perdana; Tsung-Hsing Chen; Ta-Sen Yeh; Ming-Ling Chang
delete分享
delete收藏
Using intestinal ultrasound to monitor Crohn’s disease activity and treatment response in patients: a plain language summary利用肠超声监测克罗恩病患者疾病活动度及治疗反应：一份通俗易懂的摘要
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-08
delete0
PREAI
deleteVipul Jairath; Mariangela Allocca; Silvio Danese; Marla C. Dubinsky; Christopher Ma; Torsten Kucharzik; Kerri L. Novak; Remo Panaccione; Itzel Romo Bautista; Bruce E. Sands; Stuart A. Taylor; Rune Wilkens; Stephanie A. Wynn; Christian Maaser
delete分享
delete收藏
Real-world comparative effectiveness and persistence of ustekinumab versus vedolizumab across cohort mean age in Crohn’s disease: A systematic review and meta-analysis with meta-regression克罗恩病患者中ustekinumab与vedolizumab在队列平均年龄方面的真实世界比较有效性和持久性：一项系统评价和Meta分析及Meta回归
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-08
delete0
PREAI
deleteJong Yoon Lee; Hyun Jung Kim; Jung Won Lee; Jae Hyun Kim; Seung Min Hong; Hyun-Ji Shin; Seun Ja Park
delete分享
delete收藏
Comparative efficacy of acid-suppressive and gastroprotective agents in patients with coronary heart disease on antiplatelet therapy: A systematic review and network meta-analysis抗酸剂和胃保护剂在抗血小板治疗的心脏病患者中的比较疗效：一项系统评价和网络Meta分析
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-07
delete0
PREAI
deleteYujie Zhang; Junyan Zhang; Xiaoli Fan; Xiaoyan Ao; Yong He; Zhongxiu Chen; Yu Zeng
delete分享
delete收藏
Elafibranor in selected patients with primary biliary cholangitis and cirrhosis: An exploratory real-world cohort studyElafibranor在原发性胆汁性胆管炎和肝硬化选定患者中的应用：一项探索性真实世界队列研究
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-01
delete0
PREAI
deleteNargiz Nuruzade; Ulya Oruc; Georgios Konstantis; Moritz Passenberg; Arash Dooghaie Moghadam; Jan Best; Claudia Veltkamp; Florian Alexander Seltsam; Hartmut H. Schmidt; Katharina Willuweit; Jassin Rashidi-Alavijeh
delete分享
delete收藏
Acceptability of probiotics, fecal microbiota transplantation, and emerging microbiome-derived therapies in patients with inflammatory bowel diseases: A cross-sectional Survey Study炎症性肠病患者对益生菌、粪菌移植及新兴肠道菌群衍生疗法的接受度：一项横断面调查研究
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-10-01
delete0
PREAI
deleteNathan Grellier; Clotilde Policar; Safa Hachicha; Samira Denguir; Anne Bourrier; Cecilia Landman; Isabelle Nion-Larmurier; Paul McLellan; Julien Kirchgesner; Harry Sokol; Nicolas Delsuc; Enguerran Macia; Philippe Seksik
delete分享
delete收藏
Real-world comparison of second-line infliximab and jak inhibitors for ulcerative colitis after first-line vedolizumab: A comparative multicenter study在一线维多利珠单抗治疗后，二线英夫利西单抗与JAK抑制剂的溃疡性结肠炎真实世界比较：一项多中心比较研究
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-09-30
delete0
PREAI
deleteOmer Shohat; Roni Weisshof; Ahinoam Glusman-Bendersky; Jacob E. Ollech; Henit Yanai; Uri Kopylov; Asaf Levartovsky
delete分享
delete收藏
Facilitated reintroduction of eliminated eosinophilic esophagitis trigger foods with dupilumab使用度普利尤单抗促进已排除的嗜酸性食管炎触发食物的再引入
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-09-30
delete0
PREAI
deleteJonathan M. Spergel; Nirmala Gonsalves; Ryan Piansky
delete分享
delete收藏
Prevalence of non-alcoholic fatty liver disease across populations and comorbid conditions: An umbrella review of meta-analyses非酒精性脂肪肝病的流行率及其在不同人群和共病条件下的分布：一项伞形综述研究
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-09-29
delete0
PREAI
deleteYue Feng; Peiye Wu; Rui Zhao; Xiaoding Shen; Xixuan Peng; Leyao Qiu; Can Zhu; Zhuolin Jiang; Huatian Gan; Qianyi Wan
delete分享
delete收藏
Subcutaneous infliximab for inflammatory bowel disease: Clinical evidence, pharmacokinetics, and implementation challenges皮下注射英夫利昔单抗治疗炎症性肠病：临床证据、药代动力学及实施挑战
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-09-29
delete0
PREAI
deleteMir Zulqarnain; Parakkal Deepak; Andres J. Yarur
delete分享
delete收藏
The potential benefit of sodium glucose cotransporter (SGLT)-2 inhibitors in liver cirrhosis: A mini review钠葡萄糖协同转运蛋白（SGLT）-2抑制剂在肝硬化中的潜在益处：一篇迷你综述
deleteTherapeutic Advances in Gastroenterology
IF3.4
delete2026-09-29
delete0
PREAI
deleteMichelle Spaan; Abraham S. Meijnikman; Daniel H. van Raalte; Joost P. H. Drenth
delete分享
delete收藏